Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
April 22, 2022
COVID-19 has reinforced the need for strong regulatory systems. The success of new technologies rapidly developed to mitigate the pandemic depends in no small part on key regulatory functions, such as oversight for clinical trials; review and authorization of medical products like vaccines, treatmen...
CGD NOTES
April 07, 2022
While oral antivirals are not a substitute for vaccination, they are key to preventing severe illness, saving lives, and preserving health systems. Vaccination rates continue to be low in low-income countries; only 14 percent of the population in low-income countries has received one dose of the vac...
Blog Post
April 07, 2022
While oral antivirals are not a substitute for vaccination, they help prevent severe illness, save lives, and preserve health systems. Vaccination rates continue to lag in low-income countries: only 14 percent of the population in low-income countries has received one dose of the vaccine, compared t...
CGD in the News
March 29, 2022
Contagion spoke with Anthony McDonnell, senior policy analyst, Center for Global Development and Javier Guzman, MD, director of Global Health Policy and a senior policy fellow at the Center for Global Development who offered their perspectives on the challenges of AMR in low-income and middle-income...
Blog Post
March 14, 2022
CGD's Javier Guzman speaks with the Indian National Health Authority's Shankar Prinja about the structure and benefits of the PMJAY insurance scheme, the challenges of large-scale programs, and the need for researchers and policymakers to work together to produce and make use of evidence on what wor...
CGD NOTES
March 03, 2022
The COVID-19 pandemic has transformed the global vaccine manufacturing landscape, with capacity more than doubling in the past 18 months. Before the pandemic, manufacturers produced an estimated total of five billion vaccine doses each year. In 2021, manufacturers produced 12 billion doses of C...
Feb
24
2022
9:30—11:00 AM Eastern Time (US & Canada)
February 18, 2022
As of November 5, 2021, the African Union signed into force its second specialized health agency: the African Medicines Agency (AMA). More than two years after its introduction, the AMA treaty has now been ratified by 17 African Union member countries – two more than was required – and has been...
Blog Post
February 16, 2022
One of the most prestigious HTA agencies is the National Institute for Health and Care Excellence (NICE) in England, which has gained its reputation through highly vetted, transparent, and robust processes and recommendations. For LMICs that don’t have the capacity and/or the expertise to generate t...